Skip to main content
    S

    Savara Inc (SVRA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.46
    -0.18 (-3.77%)

    Market Cap: $1.02B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Savara Inc (SVRA) Financials: Revenue, Profit and Cash Flow

    Updated Nov 9, 2026. Financial statements from company filings, amounts in US dollars.

    Savara reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was -$118.84M, operating cash flow was -$101.04M and free cash flow was -$101.06M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$42.99M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $123.55M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0N/AN/AN/AN/A
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0-100.0%N/AN/AN/A
    Dec 2021$1.00K-99.6%-2899100.0%-4147700.0%-4301400.0%
    Dec 2020$257.00KN/A-13533.5%-19182.9%-19305.4%
    Dec 2019$0N/AN/AN/AN/A
    Dec 2018$0N/AN/AN/AN/A
    Dec 2017$0-100.0%N/AN/AN/A
    Dec 2016$400.00KN/A100.0%-2737.0%-2730.8%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$0$0$0$0$1.00K$257.00K$0$0$0$400.00K
    Cost of revenue$245.00K$78.03M$44.26M$27.88M$28.99M$35.04M$38.78M$526.00K$363.00K$8.18M
    Gross profit-$245.00K-$78.03M-$44.26M-$27.88M-$28.99M-$34.78M-$38.78M-$526.00K-$363.00K$400.00K
    Research and development$81.40M$78.03M$44.26M$27.88M$28.99M$35.04M$38.78M$37.17M$18.51M$8.18M
    Operating income-$123.55M-$103.20M-$60.01M-$38.84M-$41.48M-$49.30M-$79.03M-$70.05M-$29.96M-$10.95M
    Net income-$118.84M-$95.88M-$54.70M-$38.15M-$43.01M-$49.62M-$78.17M-$61.52M-$29.80M-$10.92M
    EBITDA-$118.75M-$102.27M-$59.13M-$37.88M-$40.27M-$45.41M-$49.73M-$69.50MN/A-$10.48M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$0$0$0$0$0$0$0$272.00K$0$0$0$0
    Gross profitN/AN/A-$66.00K-$40.00K-$20.59M-$385.00K-$905.00K-$70.00K-$20.31M-$600.00K-$1.30M-$66.00K
    Operating income-$43.54M-$40.97M-$38.99M-$33.43M-$30.25M-$31.44M-$28.43M-$31.17M-$26.36M-$23.19M-$22.48M-$17.63M
    Net income-$42.99M-$40.23M-$37.28M-$32.24M-$29.56M-$30.40M-$26.64M-$29.04M-$24.25M-$22.24M-$20.35M-$16.10M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $29.91M by $3.27M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$253.44M$212.88M$177.56M$139.78M$176.60M$97.75M$136.20M$152.29M$159.63M$28.93M
    Current assets$241.62M$202.13M$165.95M$128.95M$165.00M$85.12M$124.07M$113.34M$97.86M$14.61M
    Cash and equivalents$33.18M$15.13M$26.59M$52.10M$34.01M$22.88M$49.80M$24.30M$22.12M$13.37M
    Total liabilities$50.30M$41.43M$37.19M$32.00M$32.10M$33.36M$34.51M$152.29M$40.32M$64.81M
    Short-term debt$7.00K$116.00K$143.00K$64.00K$8.47M$179.00K$2.44M$41.00K$265.00K$442.00K
    Long-term debt$29.91M$26.62M$26.35M$26.08M$17.32M$25.10M$23.11M$24.53M$14.78M$2.29M
    Shareholder equity$203.13M$171.45M$140.37M$107.78M$144.50M$64.38M$101.70M$108.22M$119.31M-$35.88M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$155.93M$192.14M$221.65M$253.44M$140.92M$163.76M$189.32M$212.88M$238.82M$139.67M$158.29M$177.56M
    Total liabilities$48.08M$48.48M$45.61M$50.30M$46.54M$43.28M$41.47M$41.43M$39.47M$37.94M$36.43M$37.19M
    Cash and equivalents$29.81M$41.80M$38.79M$33.18M$16.28M$17.44M$19.56M$15.13M$21.43M$23.86M$16.79M$26.59M
    Shareholder equity$107.85M$143.66M$176.04M$203.13M$94.39M$120.48M$147.85M$171.45M$199.35M$101.73M$121.86M$140.37M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$101.04M-$89.09M-$51.06M-$34.55M-$40.08M-$39.84M-$45.12M-$39.27M-$28.23M-$8.37M
    Capital expenditures$22.00K$25.00K$296.00K$9.00K$57.00K$3.29M$148.00K$141.00K$495.00K$8.00K
    Free cash flow-$101.06M-$89.11M-$51.36M-$34.56M-$40.14M-$43.13M-$45.27M-$39.42M-$28.73M-$8.38M
    Dividends paidN/AN/AN/AN/AN/A$2.12MN/AN/A$0$0
    Investing cash flow-$18.44M-$39.94M-$57.12M$52.65M-$69.46M$9.05M$15.74M-$13.62M-$69.11M-$8.00K
    Financing cash flow$137.81M$117.58M$82.78M$87.00K$120.81M$3.69M$54.91M$55.19M$106.09M$5.12M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$42.46M-$29.75M-$33.05M-$25.06M-$22.53M-$26.26M-$27.19M-$23.28M-$22.67M-$22.50M-$20.64M-$15.60M
    Capital expenditures$353.00K$222.00K$54.00K$2.00K$2.00K$15.00K$3.00K$9.00K$3.00K$21.00K$10.00K$24.00K
    Free cash flow-$42.82M-$29.97M-$33.10M-$25.06M-$22.53M-$26.28M-$27.19M-$23.29M-$22.67M-$22.52M-$20.65M-$15.63M
    Last 12 quarters

    Frequently Asked Questions About SVRA

    What is Savara's annual revenue?

    Savara reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    Is Savara profitable?

    No. Savara reported net income of -$118.84M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does SVRA generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$101.04M minus capital expenditures of $22.00K produced free cash flow of -$101.06M.

    How much debt does Savara have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $29.91M, short-term debt of $7.00K and cash and equivalents of $33.18M.